Publications
2024
Contributors to Organ Damage in Childhood Lupus: Corticosteroid Use and Disease Activity.
Hanif, M., Sarker, C., Al-Abadi, E., Armon, K., Bailey, K., Bohm, M., . . . Smith, E. M. D. (2024). Contributors to Organ Damage in Childhood Lupus: Corticosteroid Use and Disease Activity.. Rheumatology (Oxford, England), keae592. doi:10.1093/rheumatology/keae592
OP0246 FACTORS ASSOCIATED WITH DAMAGE ACCRUAL IN CHILDHOOD SYSTEMIC LUPUS ERYTHEMATOSUS (cSLE): CORTICOSTEROID REGIMENS AND MAINTENANCE OF LOW DISEASE ACTIVITY
Hanif, M., Sarker, C., Beresford, M. W., & MD Smith, E. (2024). OP0246 FACTORS ASSOCIATED WITH DAMAGE ACCRUAL IN CHILDHOOD SYSTEMIC LUPUS ERYTHEMATOSUS (cSLE): CORTICOSTEROID REGIMENS AND MAINTENANCE OF LOW DISEASE ACTIVITY. In Scientific Abstracts (pp. 227.1-228). BMJ Publishing Group Ltd and European League Against Rheumatism. doi:10.1136/annrheumdis-2024-eular.1166
OP0277 EVALUATING THE IMPACT OF CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS T2T TARGET ATTAINMENT: MITIGATING FLARES AND NEW DAMAGE ACCRUAL
Sarker, C., Jorgensen, A. L., Beresford, M. W., & MD Smith, E. (2024). OP0277 EVALUATING THE IMPACT OF CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS T2T TARGET ATTAINMENT: MITIGATING FLARES AND NEW DAMAGE ACCRUAL. In Scientific Abstracts (pp. 229). BMJ Publishing Group Ltd and European League Against Rheumatism. doi:10.1136/annrheumdis-2024-eular.697
POS0173 EVALUATING CHILDHOOD LUPUS LOW DISEASE ACTIVITY STATE (cLLDAS) AS A POTENTIAL TREAT-TO-TARGET TREATMENT ENDPOINT: A VALIDATION AND SENSITIVITY ANALYSIS
Smith, E. M., Sarker, C., Jorgensen, A. L., & Beresford, M. W. (2024). POS0173 EVALUATING CHILDHOOD LUPUS LOW DISEASE ACTIVITY STATE (cLLDAS) AS A POTENTIAL TREAT-TO-TARGET TREATMENT ENDPOINT: A VALIDATION AND SENSITIVITY ANALYSIS. In Scientific Abstracts (pp. 529). BMJ Publishing Group Ltd and European League Against Rheumatism. doi:10.1136/annrheumdis-2024-eular.5896